Psoriasis Treatment Market Comprehensive Analysis, Top Companies, Revenue and Growth Factors Details, Future Strategic Planning and Forecast to 2026

Psoriasis Treatment Market report covers top players as AbbVie Inc., Novartis AG, Johnson & Johnson Services, Inc., Pfizer Inc., , LEO Pharma A/S, Merck & Co., Inc., Amgen Inc., Eli Lilly and Company , CELGENE CORPORATION, UCB S.A., Sun Pharmaceutical Industries Ltd., Other prominent players

The rising prevalence of psoriasis cases is fueling the demand among patients and enabling the growth of the global psoriasis treatment market says Fortune Business insights in a report titled  “Psoriasis Treatment Market Size, Share and Global Trend By Treatment (Bipolar Psoriasis Treatment, Topical Treatments, Oral Or Injected Medications, Phototherapy, Others), By Route of Administration (Oral, Topical, Parenteral, Rectal, Sublingual), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales), And Geography Forecast Till 2026”. Increasing research and development on psoriasis treatment is propelling the growth of the psoriasis treatment market

Top Leaders Overview:

Some of the leading companies in the global Psoriasis Treatment Market:

  • UCB
  • Novartis
  • Boehringer Ingelheim International GmbH
  • Amgen
  • LEO Pharma
  • Pfizer
  • Eli Lilly and Company
  • Johnson & Johnson
  • Merck
  • AstraZeneca
  • Celgene Corporation

Get Sample PDF Brochure:

Increasing R&D for Psoriasis Treatment to Aid Market Growth

Psoriasis is a chronic autoimmune disease, categorized by conditions which involve itchy dry patches and skin cells building up and forming scales. There is no such cure for the disease, so most of the emphasis of the treatment rests on the easing of symptoms. The course of treatment is determined by a number of factors such as the severity of psoriasis, the treatments already used, the existence of other medical conditions, the amount of treatment the patient is willing to do and the insurance plan of the patient.

Factors which cause psoriasis include environmental triggers such as stress, injury to skin, infection, certain medications; the genetics of the patients; the immune system; the existence of comorbidities such as diabetes, Crohn’s Disease, high cholesterol, high blood pressure, depression, and cardiovascular diseases, etc. The rising cases of the aforementioned diseases are fueling the demand for psoriasis treatment and fostering the growth for psoriasis treatment market.

Psoriasis treatment market is witnessing a rising demand in response tothe increasing incidence of the disease across many countries. This is also due to the fact, that psoriasis is associated with various other diseases such as obesity, diabetes, cardiovascular diseases thus making it an upward trend for the global market. According to The World Health Organization (WHO), the prevalence of psoriasis in the U.S. has increased from 1.62% in 2004 to 3.10% in 2010. In Norway, a 30-year period study observed that Psoriasis in adults increased from 4.8% in 1979 to 11.4% in 2008. The rising prevalence of psoriasis cases, the new drug approvals from Food and Drug Administration (FDA), and increasing research and development along with new scientific discoveries are some of the factors that are expected to propel the growth of the global psoriasis market.

FDA Approves TREMFYA™; Novel Drug Approvals to Aid Market Expansion 

Janssen Biotech, Inc., a biotechnology company unveiled TREMFYA™ for the treatment of severe plaque psoriasis and systematic therapy in adults, after getting approval from the Food and Drug Administration. The company claimed that TREMFYA™-treated patients can achieve at least 90 percent clearer skin and improvements involving the scalp, stinging, burning and skin tightness at week 16. The treatment being the first and only biologic therapy is expected to witness high demand among patients to avail the therapy which will, in turn, boost the Psoriasis treatment market.  Key players are launching new drugs and therapies for the treatment of psoriasis for instance, in 2018 Sun Pharmaceutical Industries Ltd., received European Commission approval for plaque psoriasis treatment tildrakizumab (Ilumetri). New initiatives by companies for treating severe and moderate psoriasis are predicted to drive the global psoriasis market.

Browse Complete Report:

North America to Dominate the Global Market

Geographically, the global psoriasis treatment market is segmented into North America, Europe, Asia-Pacific, Latin America. North America is leading the global psoriasis treatment market and is expected to grow at a substantial rate during the forecast period. Rising prevalence of psoriasis, increasing health infrastructure along with the presence of leading companies is expected to boost the psoriasis treatment market. Asia- Pacific is predicted to grow at a moderately low rate, owing to the fewer cases of psoriasis in countries such as India, China and others

Some of the major companies that are present in the global psoriasis treatment market are UCB S.A, Novartis AG, Boehringer Ingelheim International GmbH, Amgen Inc., LEO Pharma A/S, Pfizer Inc., Eli Lilly and Company, Johnson & Johnson Services, Inc., Merck & Co., AstraZeneca, and Celgene Corporation. and others.

View Related Reports:

Blood Glucose Meters Market to reach US$ 15,415.6 Mn by 2026, exhibiting a CAGR of 9.6% | Fortune Business Insights

Botulinum Toxin Market to Rise Impressively at 8.0% CAGR, Huons’ Latest Launch of Botulinum Toxin Products to Enable Market Growth, says Fortune Business Insights

Cannabis Market to Exhibit 32.6% CAGR; Legalization of Medical Marijuana in Most Countries to Propel Growth, Says Fortune Business Insights


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *